Keywords: Sweden MPA, APIs, Environment, Manufacturing, EU, India, Developing countries, Certification, GMP

Swedish proposals for stricter environmental requirements for pharma industry could impact API makers in countries such as India

Article | 28 January 2010

Under a commission from the Swedish government, the nation’s Medical Products Agency (MPA) has identified opportunities for strengthening the environmental requirements relating to the manufacturing of medicinal products with greatest emphasis on European Union and international efforts rather than national work. The report suggests, among other, the requirement for an environmental certification of the production facilities to be introduced to the legislation on Good Manufacturing Practice (GMP).

Results from Swedish research indicate that emissions from the manufacture of medicinal products in India are of an extent which might seriously affect human and animal health, as well as their environment. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in